Drug intelligence / Profile preview

4-({4-[(4-aminobut-2-ynyl)oxy]phenyl}sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a small molecule with the molecular formula C17H23N3O5S2 and an average mass of approximately 413.51 Da[1][3]. It features a thiomorpholine core substituted with a benzenesulfonamide group and an N-hydroxylated carboxamide. The structure also includes an amino-substituted butynyl ether linkage to the phenyl ring. There is limited publicly available information regarding its biological activity or clinical development status.

Other names
4NH(3S)-4-({4-[(4-Amino-butynyl)oxy]phenyl}sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholinecarboxamide3-Thiomorpholinecarboxamide, 4-[ [ [ (amino-butynyl)oxy ] phenyl ] sulfonyl ] -N-hydroxy-, (3S)-
02

Targets

MMP9 (Matrix metalloproteinase-9)ADAM17 (A disintegrin and metalloprotease 17)MMP1 (Matrix metalloproteinase-1)MMP13 (Matrix metalloproteinase-13)

Beyond the preview

Go deeper on 4-({4-[(4-aminobut-2-ynyl)oxy]phenyl}sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-({4-[(4-aminobut-2-ynyl)oxy]phenyl}sulfonyl)-N-hydroxy-2,2-dimethylthiomorpholine-3-carboxamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call